FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W56723042> ?p ?o ?g. }

• W56723042 endingPage "754" @default.
• W56723042 startingPage "747" @default.
• W56723042 abstract "To assess comparatively, in terms of quality-adjusted survival, three front-line treatments in patients with stage B- or C-chronic lymphocytic leukemia (CLL). To describe better and compare the survival after randomization of patients from the CLL90 trial that randomly compared ChOP (cyclophosphamide, doxorubicin, oncovin, prednisone), CAP (cyclophosphamide, doxorubicin, prednisone) and fludarabine in advanced CLL, we performed a quality-adjusted survival analysis. This consisted of defining four clinical states (toxicity, treatment free of toxicity, no treatment nor symptoms, relapse), then summing up the average times spent in each state weighted by utility coefficients that reflect relative value according to quality of life. The resulting quality-adjusted time without symptoms or toxicity (Q-TWIST) was compared between randomized groups, and sensitivity (threshold) analyses to the choice of utility coefficients was performed. Over 73 months after randomization, the fludarabine group gained a mean of 45 days of toxicity-free survival at CAP, and 61 days over ChOP. The mean TWIST was 27.05 months with CAP, 31.5 months with ChOP and 32.95 months with fludarabine. The threshold analyses showed that, whatever the utility weights, the mean Q-TWIST was always greater with ChOP or fludarabine as compared to CAP. Fludarabine was consistently a better treatment than ChOP, except in the unlikely case of high utility weights attributed to toxicity and low utility weights attributed to treatment. Nevertheless, from a clinical point of view, differences between ChOP and fludarabine were moderate or event slight (mean difference in TWIST of 1.45 months). We conclude that patients with advanced CLL have a moderate benefit in terms of Q-TWIST when treated with fludarabine over ChOP. These two treatments are always superior to CAP." @default.
• W56723042 created "2016-06-24" @default.
• W56723042 creator A5017512905 @default.
• W56723042 creator A5044409234 @default.
• W56723042 creator A5052673276 @default.
• W56723042 creator A5057098654 @default.
• W56723042 creator A5066493529 @default.
• W56723042 creator A5090578290 @default.
• W56723042 date "2001-07-01" @default.
• W56723042 modified "2023-10-01" @default.
• W56723042 title "Evaluating treatment strategies in chronic lymphocytic leukemia" @default.
• W56723042 cites W182568540 @default.
• W56723042 cites W1939111644 @default.
• W56723042 cites W1965851569 @default.
• W56723042 cites W1972018249 @default.
• W56723042 cites W1974095075 @default.
• W56723042 cites W2055037217 @default.
• W56723042 cites W2070193300 @default.
• W56723042 cites W2073619309 @default.
• W56723042 cites W2079902458 @default.
• W56723042 cites W2116248495 @default.
• W56723042 cites W2132757216 @default.
• W56723042 cites W2147614420 @default.
• W56723042 cites W2160889655 @default.
• W56723042 cites W2161926682 @default.
• W56723042 cites W2170430904 @default.
• W56723042 cites W2179977652 @default.
• W56723042 cites W2243208599 @default.
• W56723042 cites W2254058470 @default.
• W56723042 cites W2259708582 @default.
• W56723042 cites W2265847092 @default.
• W56723042 cites W2317888977 @default.
• W56723042 cites W2323490326 @default.
• W56723042 cites W2343398839 @default.
• W56723042 cites W2415224001 @default.
• W56723042 cites W3041047318 @default.
• W56723042 cites W4252663390 @default.
• W56723042 cites W60865865 @default.
• W56723042 cites W96780237 @default.
• W56723042 doi "https://doi.org/10.1016/s0895-4356(00)00359-0" @default.
• W56723042 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11438417" @default.
• W56723042 hasPublicationYear "2001" @default.
• W56723042 type Work @default.
• W56723042 sameAs 56723042 @default.
• W56723042 citedByCount "52" @default.
• W56723042 countsByYear W567230422012 @default.
• W56723042 countsByYear W567230422013 @default.
• W56723042 countsByYear W567230422014 @default.
• W56723042 countsByYear W567230422015 @default.
• W56723042 countsByYear W567230422017 @default.
• W56723042 countsByYear W567230422018 @default.
• W56723042 countsByYear W567230422020 @default.
• W56723042 countsByYear W567230422021 @default.
• W56723042 countsByYear W567230422023 @default.
• W56723042 crossrefType "journal-article" @default.
• W56723042 hasAuthorship W56723042A5017512905 @default.
• W56723042 hasAuthorship W56723042A5044409234 @default.
• W56723042 hasAuthorship W56723042A5052673276 @default.
• W56723042 hasAuthorship W56723042A5057098654 @default.
• W56723042 hasAuthorship W56723042A5066493529 @default.
• W56723042 hasAuthorship W56723042A5090578290 @default.
• W56723042 hasConcept C126322002 @default.
• W56723042 hasConcept C141071460 @default.
• W56723042 hasConcept C143998085 @default.
• W56723042 hasConcept C204243189 @default.
• W56723042 hasConcept C2776694085 @default.
• W56723042 hasConcept C2776755627 @default.
• W56723042 hasConcept C2777938653 @default.
• W56723042 hasConcept C2778461978 @default.
• W56723042 hasConcept C2778720950 @default.
• W56723042 hasConcept C2779263901 @default.
• W56723042 hasConcept C2779725641 @default.
• W56723042 hasConcept C535046627 @default.
• W56723042 hasConcept C71924100 @default.
• W56723042 hasConcept C90924648 @default.
• W56723042 hasConceptScore W56723042C126322002 @default.
• W56723042 hasConceptScore W56723042C141071460 @default.
• W56723042 hasConceptScore W56723042C143998085 @default.
• W56723042 hasConceptScore W56723042C204243189 @default.
• W56723042 hasConceptScore W56723042C2776694085 @default.
• W56723042 hasConceptScore W56723042C2776755627 @default.
• W56723042 hasConceptScore W56723042C2777938653 @default.
• W56723042 hasConceptScore W56723042C2778461978 @default.
• W56723042 hasConceptScore W56723042C2778720950 @default.
• W56723042 hasConceptScore W56723042C2779263901 @default.
• W56723042 hasConceptScore W56723042C2779725641 @default.
• W56723042 hasConceptScore W56723042C535046627 @default.
• W56723042 hasConceptScore W56723042C71924100 @default.
• W56723042 hasConceptScore W56723042C90924648 @default.
• W56723042 hasIssue "7" @default.
• W56723042 hasLocation W567230421 @default.
• W56723042 hasLocation W567230422 @default.
• W56723042 hasOpenAccess W56723042 @default.
• W56723042 hasPrimaryLocation W567230421 @default.
• W56723042 hasRelatedWork W160156331 @default.
• W56723042 hasRelatedWork W2044931406 @default.
• W56723042 hasRelatedWork W2118537066 @default.
• W56723042 hasRelatedWork W2321725760 @default.

• next